CLINICAL_TRIALS
trial_result
· 2024-05-03
Clinical Trial Update: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents [Phase 3]
Summary
Phase 3 multicenter study evaluating safety and immunogenicity of a live-attenuated chikungunya vaccine in adolescents; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Butantan Institute | Conditions: Chikungunya | Phase 3 | Status: COMPLETED